Join to View Full Profile
1364 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-2144
Dr. Dhodapkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Saint Louis University School of MedicineResidency, 1988 - 1990
Aurora Health CareResidency, Internal Medicine, 1987 - 1988
All India Institute of Medical SciencesClass of 1987
Certifications & Licensure
GA State Medical License 2018 - 2026
CT State Medical License 2008 - 2019
NY State Medical License 1998 - 2010
AR State Medical License 1994 - 1999
MN State Medical License 1990 - 1995
WI State Medical License 1989 - 1991
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Balancing the Scales: Optimizing Reporting of Infection Rates in Clinical Trials of Bispecific Antibodies in Multiple Myeloma.Joshua Richter, Madhav V Dhodapkar, Mengying Li, Mina Awad, Christian Hampp
American Journal of Hematology. 2025-04-01 - Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer.Changfa Shu, Jianfeng Li, Jin Rui, Dacheng Fan, Qiankun Niu
Nature Communications. 2025-03-08 - 1 citationsImmune-aging is linked to clinical malignancy, racial ancestry and vaccine responses in myeloma.Sayalee V Potdar, Shivani Kapadia, Maryam I Azeem, Roman Radzievski, Kiran Lakhani
Blood Advances. 2025-02-05
Grant Support
- Improving immune modulation for smoldering myelomaEMORY UNIVERSITY2024–2029
- Improving immune modulation for smoldering myelomaEMORY UNIVERSITY2024–2029
- Improving immune modulation for smoldering myelomaEMORY UNIVERSITY2024–2029
- Targeting microbial triggers of gammopathy for immunopreventionEMORY UNIVERSITY2024–2026
- Targeting microbial triggers of gammopathy for immunopreventionEMORY UNIVERSITY2024–2026
- Targeting microbial triggers of gammopathy for immunopreventionEMORY UNIVERSITY2024–2026
- Targeting microbial triggers of gammopathy for immunopreventionEMORY UNIVERSITY2024–2026
- Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"EMORY UNIVERSITY2020–2025
- Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"EMORY UNIVERSITY2020–2025
- Immune Regulation of COVID-19 Infection in Cancer and AutoimmunityEMORY UNIVERSITY2020–2025
- Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"EMORY UNIVERSITY2020–2025
- Immune Regulation of COVID-19 Infection in Cancer and AutoimmunityEMORY UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
